RESCISSION, RESTRUCTURING
AND ASSIGNMENT AGREEMENT
This
Rescission, Restructuring and Assignment Agreement (this
"AGREEMENT")
is entered into as of January 27, 2005, by and among Integrated Healthcare
Holdings, Inc., a Nevada corporation (the
"COMPANY"), Kali P.
Chaudhuri, M.D.
("DR. CHAUDHURI"), William E. Thomas ("THOMAS") (for
purposes of Sections 3 and
10 only), Anil V. Shah, M.D. ("DR.
SHAH") (for purposes
of Sections 2(a) and 9
only), and Orange County Physicians
Investment
Network, LLC, a Nevada limited
liability company ("OC-PIN").
R E C I T A L S
A. The
Company and Dr. Chaudhuri are parties to a Secured Convertible
Note
Purchase Agreement dated as of September
28, 2004, which was amended by a First
Amendment to Secured Convertible Note Purchase Agreement dated as of November
16, 2004 (collectively, the "PURCHASE AGREEMENT"), pursuant to which Dr.
Chaudhuri was issued a $500,000 Secured Convertible Promissory Note
("CONVERTIBLE NOTE"), a $10,000,000 Secured Promissory Note ("SECURED
NOTE"),
and a Stock Option Agreement dated November
16, 2004 ("STOCK OPTION AGREEMENT").
B. The
Company is in default of its obligation to repay the Convertible
Note by December 31, 2004.
C. The
Company desires that OC-PIN invest in the Company.
D. Dr.
Chaudhuri and Dr. Shah, an authorized representative and affiliate
of OC-PIN, are parties to a
Non-Circumvention
Agreement dated November 11, 2004
("NON-CIRCUMVENTION AGREEMENT").
E. As a
condition to investment, OC-PIN has requested that the
Convertible
Note, the Secured Note, the Stock Option
Agreement and certain provisions of the
Agreement be rescinded and canceled, and
Dr. Chaudhuri restructure his financial
arrangements with the Company, and that he terminate the Non-Circumvention
Agreement. Dr. Chaudhuri is willing to reduce his contractual rights and
participation and otherwise accommodate the Company and OC-PIN
on the terms and
subject to the conditions set forth in this
Agreement.
F. The
parties acknowledge
that Dr. Chaudhuri had
the right to acquire a
majority interest in the Company, which right he has agreed (subject to the
conditions herein) to rescind, and accept in its place stock
purchase warrants
in favor of Dr. Chaudhuri and Thomas to acquire only up to
(and not to exceed)
24.9% of the Company's capital stock, which
warrants are not exercisable for two
years from the date of issuance, and the Company and OC-PIN are willing to
consent to this arrangement.
G. The
Company is a party to
a definitive
Asset Sale
Agreement,
dated
September 29, 2004 (the "ASSET SALE
AGREEMENT"),
pursuant to which the
Company
has agreed to purchase four hospitals from subsidiaries of Tenet Healthcare
Corporation located in Orange County, California, known as Western Medical
Center - Santa Ana, Western Medical Center - Anaheim, Costal Communities
Hospital, and Chapman Medical Center.
The transactions
contemplated under
the
Asset Sale Agreement are collectively referred to herein as the "TENET
TRANSACTION".
1
<PAGE>
H. The
Tenet Transaction
has not yet closed,
and the parties
desire to
reflect and memorialize certain understandings among them with respect to the
Tenet Transaction. This Agreement is expressly conditioned upon Tenet's
acceptance of the restructuring contemplated by this Agreement and
its release
of Dr. Chaudhuri from his guarantee of the
Chapman lease.
A G R E E M E N T
In
consideration
of the foregoing premises, the mutual covenants and
agreements set forth herein, and for other
good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, and subject to
satisfaction of the conditions set forth in
Section 9, the parties hereto hereby
agree as follows:
1.
DEFINITIONS. For the
purposes of this Agreement (including amendments
to the Purchase Agreement contained herein), (i) unless otherwise set forth
herein, capitalized terms or matters of construction
deemed or established
in
the Purchase Agreement, as amended hereby,
shall be applied herein as defined or
established therein, and (ii) the term "FULLY-DILUTED" includes all shares of
Common Stock of the Company issued and
outstanding at the
date in question plus
all shares of Common Stock of the Company issuable (whether or not vested) at
that date upon full exercise of all
options, warrants or other rights to acquire
Common Stock of the Company and full
conversion of all
securities
convertible
into Common Stock of the Company, but excluding from that amount up to
10,000,000 shares (or rights to acquire shares) of Common Stock per year to
employees, consultants, officers or directors of the
Company pursuant to stock
option or restricted stock plans or agreements
approved by the
Company's Board
of Directors.
2.
RESCISSION
AND CANCELLATION OF NOTES, OPTION, NON-CIRCUMVENTION
AGREEMENT AND CERTAIN PROVISIONS OF
PURCHASE AGREEMENT.
(a) Upon fulfillment
of the conditions set
forth in Section 9, the
Convertible Note, the Secured Note, the Stock Option Agreement and the
Non-Circumvention Agreement are hereby rescinded and canceled.
Within two (2)
business days after receipt of the
$10,000,000 plus accrued interest referred to
in Section 6, Dr. Chaudhuri shall, and he shall cause his
attorneys and agents
to, (i) return to the Company the originals of the Convertible Note and the
Secured Note for cancellation and (ii) deliver to
OC-PIN copies of all material
agreements executed by Dr. Chaudhuri with the
Company or in connection with the
Tenet Transaction. Except as provided in this
Agreement with respect to Thomas,
Dr. Chaudhuri hereby represents and warrants to the Company that
he has not,
directly or indirectly, transferred, sold or syndicated any part of the
securities that he received or was entitled
to acquire from the Company.
(b) The Purchase Agreement is hereby rescinded and canceled,
except
that the provisions of: (i) Section 1.7 thereof shall remain in effect (as
amended by Section 4 below) (ii)
Article II thereof
shall remain in effect
(as
amended by Section 4 below) and shall be applicable to the shares of the
Company's Common Stock issuable pursuant to
the warrants described
in Section 3
below; (iii) Articles III and IV thereof shall remain in effect and the
provisions thereof shall be deemed to apply with respect to the issuances
described in Section 3 below; and (iv) Section 5.3 thereof shall remain in
effect for the benefit of both Dr.
Chaudhuri and Thomas for so long as either of
them holds either stock purchase warrants
pursuant to the new warrants described
in Section 3 below or shares of the
Company's Common Stock obtained by them upon
exercise thereof, provided, however that (A) Section 5.3 shall
terminate and
cease to have effect upon an acquisition of the Company by an unrelated
third
party and (B) each of Dr. Chaudhuri and Thomas shall execute appropriate
confidentiality agreements in customary form with respect to information
obtained pursuant to these sections.
2
<PAGE>
(c) Dr. Chaudhuri
agrees to reasonably
cooperate with the
Company
and California Department of Health Services at no or minimal cost to Dr.
Chaudhuri by providing information and other reasonable
assistance so that
the
Company may promptly complete the Tenet Transaction and
obtain licensing of the
hospital facilities to be acquired therein;
provided that such cooperation shall
not result in any material modification to
this Agreement.
3.
ISSUANCE OF NEW
NON-CONVERTIBLE
NOTES AND WARRANTS; ASSIGNMENT TO
THOMAS. The Company has agreed to issue to Dr. Chaudhuri (i) a new
non-convertible secured promissory note
reflecting amounts loaned to the Company
by Dr. Chaudhuri as well as expenditures
made by Dr. Chaudhuri
on the Company's
behalf or for the Company's benefit, plus accrued interest to date, and
(ii) a
new stock purchase warrant reflecting the right to purchase shares of the
Company's Common Stock. Dr. Chaudhuri has assigned to Thomas
certain of his
rights with respect thereto, to which assignments the Company
and OC-PIN hereby
consent. As a result of the assignment,
the parties
acknowledge and agree that,
within 48 hours after the execution of this
Agreement,
but dated and
effective
as of the date of this Agreement, the
Company shall issue to (A) Dr. Chaudhuri a
non-convertible secured promissory note, in substantially
the form of
Exhibit
A-1, and in a principal amount equal to 80% of the sum of
all amounts loaned by
Dr. Chaudhuri to the Company or paid,
advanced or incurred
by Dr. Chaudhuri on
behalf or for the benefit of the
Company, or in connection with the Purchase
Agreement and related documents, or in connection with the Tenet Transaction
(collectively, the "ADVANCES"), (B) Thomas a
non-convertible secured promissory
note, in substantially the form of Exhibit A-2, and in a
principal amount equal
to 20% of the Advances (collectively, the "NEW NOTES"), (C) Dr. Chaudhuri a
stock purchase warrant reflecting the right to purchase
up to 60,000,000 shares
of the Company's Common Stock (but not to exceed 20% of the Company's
Fully-Diluted capital stock) in substantially the form of Exhibit B-1 and
(D)
Thomas a stock purchase warrant reflecting the right to purchase up to
14,700,000 shares of the Company's
Common Stock (but not
to exceed 4.9% of the
Company's Fully-Diluted capital stock) in
substantially the form of Exhibit B-2
(collectively, the "NEW WARRANTS"). Repayment of the New Notes shall be
guaranteed by OC-PIN pursuant to a General
Continuing Guaranty
substantially in
the form of Exhibit C.
4. CERTAIN
AMENDMENTS.
(a) Section
1.7 of the
Purchase Agreement is hereby amended by
deleting it in its entirety and replacing
it with the following:
3
<PAGE>
"1.7 PRE-EMPTIVE RIGHTS.
1.7.1 GENERAL
PRE-EMPTIVE RIGHT.
Provided that Purchaser and
William E. Thomas
("THOMAS") have
exercised their Stock Purchase
Warrants dated
January 17, 2005, the Company hereby grants to
Purchaser and Thomas a right of first refusal with respect to
future
sales by the Company of its equity securities or securities
convertible into
or exercisable for equity securities, where
issuance of those securities would result in dilution of
Purchaser's
and Thomas's
combined equity position to less than 24.9% of the
Common Stock of the Company on a Fully-Diluted basis. Each time the
Company proposes to
offer any shares of, or securities convertible
into or exercisable
for any shares of, any
class of the
Company's
equity securities
which would reduce Purchaser's and Thomas's
combined equity
position to below 24.9% (the "NEW
SHARES"), the
Company shall first
make an offer to
Purchaser and Thomas
of such
portion of the New
Shares which
would maintain Purchaser's and
Thomas's combined
equity position at a minimum of 24.9%
(the "PRO
RATA SHARE").
The closing of the sale of the Pro
Rata Share shall
occur simultaneously
with the sale of the New Shares to other
investors, and the Pro
Rata Share shall be priced equal to the
lowest price paid by any of the other investors, including any who
may be purchasing
New Shares by virtue
of similar pre-emptive
or
other purchase rights.
1.7.2 TAG-ALONG RIGHT
RELATING TO OC-PIN.
The Company hereby
grants to Purchaser
and Thomas a purchase right with respect to
future issuances by
the Company of any of its securities to Anil V.
Shah, M.D.
or Orange County Physicians Investment Network, or
affiliates of either of them (collectively, "OC-PIN GROUP"), where
the issuance of such additional shares of Common Stock would
result
in the OC-PIN Group having been issued, in the aggregate,
more than
187,240,000 shares of
the Company's Common Stock on a Fully-Diluted
basis (as adjusted for any stock splits, dividends, combinations or
the like). Upon
satisfaction
of these conditions, Purchaser and
Thomas shall
have the right to acquire, for a period of 90 days
following notification
by the Company to
Purchaser and Thomas that
the pre-emptive
right is triggered (which notice shall be given
within 10 business days of such trigger), the same securities, and
at the same price, as the member of the OC-PIN Group purchasing the
Company's securities,
in an amount that represents the same
proportion as
Purchaser's
and Thomas's
combined holdings of the
Company's Common Stock on a Fully-Diluted basis bears to the OC-PIN
Group's combined
holdings of the Company's Common Stock on a
Fully-Diluted basis immediately prior to the issuance in
question.
1.7.3 EXCLUSIONS. The
rights in this Section 1.7 shall not be
applicable to the issuance or sale of (i) securities issued
pursuant
to stock splits, stock
dividends,
or similar
transactions;
(ii)
shares of Common Stock issued to employees, consultants, officers
or
directors of
the company pursuant to stock option plans or
restricted stock plans or agreements approved by the Company's
Board
of Directors; (iii)
securities issued to financial institutions or
lessors in connection with commercial credit arrangements,
equipment
financings, commercial
property lease transactions, or similar
transactions
approved by the Board of Directors and not for the
purpose of raising capital, (iv) shares of Common Stock issued in
an
underwritten public offering; or (v) securities issued in
connection
with bona fide
acquisition
transactions approved
by the Board of
Directors.
4
<PAGE>
1.7.4 TERMINATION. The
pre-emptive rights in this Section 1.7
shall terminate and cease to have effect upon the earlier of (i)
the
closing of an acquisition of the Company to an unrelated third
party
or (ii) the later of
one-half (3 1/2)
years from the date of
this
Agreement or the
termination
of any similar pre-emptive rights
granted to OC-PIN or its affiliates."
(b) Article
II of the Purchase Agreement is hereby amended to
reflect that references to "Purchaser" or "the Holder" shall now mean Dr.
Chaudhuri and Thomas. The definition of "REGISTRABLE
SECURITIES"
contained in
Section 2.1 of the Purchase Agreement is hereby deleted in its entirety and
replaced with the following:
"`REGISTRABLE SECURITIES' means, collectively, any shares of common
stock of the Company issued to Kali P. Chaudhuri, M.D. or William
E.
Thomas pursuant
to Stock Purchase Warrants issued to those
individuals on
January 17, 2005, and any securities issued or
issuable upon any
stock dividend,
stock split,
recapitalization,
merger, consolidation
or similar event with
respect to such shares
of common stock. As to any particular Registrable Securities, such
securities shall
cease to be Registrable Securities when (i) a
registration statement
covering such
securities shall have
become
effective under the
1933 Act and such
securities shall
have been
disposed of in accordance with such registration statement, (ii)
such securities shall
have been distributed
to the public, or
all
such securities may be sold publicly without registration,
pursuant
to Rule 144 or Rule 144A (or any successor provisions ) under the
1933 Act, or (iii) such securities shall have ceased to be
outstanding."
5.
AMENDMENT OF SECURITY
AGREEMENT. The
Security Agreement
between the
Company and Dr. Chaudhuri dated September
28, 2004, is hereby amended to provide
that the secured parties are Dr. Chaudhuri
and Thomas, and that
the obligations
secured are the obligations under the New
Notes and any other obligations of the
Company to Dr. Chaudhuri arising thereunder or under this
Agreement;
however,
the security interest securing the New Notes shall be
terminated effective
at
the closing of the Tenet Transaction. Dr. Chaudhuri (and Thomas if
necessary)
shall execute and, if requested by the Company and the lender in the
Tenet
Transaction, deliver to the escrow agent for
the Tenet Transaction
an executed
UCC termination statement to accomplish the
foregoing.
5
<PAGE>
6. PAYMENT
TO DR. CHAUDHURI;
CERTAIN DISCLAIMERS. On the date of approval
of this Agreement by Tenet as contemplated by Section 9, OC-PIN shall pay,
or
shall cause the Company to pay, or shall cause to be released
from the Escrow
Fund, $10,000,000 plus the accrued interest
in the Escrow Fund to Dr. Chaudhuri,
in immediately available funds. Nothing in
this Agreement or any of the exhibits
hereto shall be effective or of any force and effect
until Dr. Chaudhuri has
received this payment of $10,000,000
plus accrued
interest. Any agreements or
arrangements between OC-PIN and the Company
with respect to this payment of
$10,000,000 plus accrued interest shall be pursuant to a separate
agreement
between them, and Dr. Chaudhuri shall have no involvement therewith or
responsibility therefor. Furthermore, Dr. Chaudhuri makes, and the
Company and
OC-PIN expressly acknowledge that Dr. Chaudhuri has
made, no representations or
warranties to OC-PIN or the Company or any of
their affiliates
regarding the
Company, OC-PIN, OC-PIN's financial wherewithal, the Tenet Transaction,
the
financing related to the Tenet Transaction (or the Company's
ability to obtain
it), licensing (or the Company's ability to obtain it) or any other matter
relating in any way to OC-PIN's
investment in or other
financial arrangements
with the Company. Each of the Company and OC-PIN has
done its own
independent
investigation of the other, and is fully satisfied with the results of those
investigations. The Company and OC-PIN
hereby agree to
indemnify,
defend and
hold Dr. Chaudhuri harmless from and against any
claims, liabilities or
losses
incurred by either of them as a result of
the financial
or other arrangements
between them.
7.
AMENDMENT AND EXERCISE OF AMENDED AND
RESTATED REAL ESTATE
PURCHASE
OPTION. Pursuant to Section 3 of the
Option Agreement dated September 28, 2004,
as amended and restated on November 16, 2004 ("LLC OPTION AGREEMENT"), Dr.
Chaudhuri currently has an option to
purchase 100% of the membership interests
of the LLC (as defined in the LLC Option
Agreement)
for $5,000,000. The LLC
Option Agreement is hereby amended to
provide that Dr.
Chaudhuri's option shall
be to purchase 49% of the membership
interests of the LLC
for $2,450,000,
and
may be assigned to and exercised by an
affiliate of Dr. Chaudhuri. Dr. Chaudhuri
hereby exercises that option, as so amended, such exercise to be
conditioned
upon, and effective at, the Closing (as
defined in the Asset Sale Agreement) of
the Tenet Transaction. The exercise is also conditioned
upon (a) receipt by Dr.
Chaudhuri of receipt of evidence
satisfactory
to him that OC-PIN has
acquired
the remaining 51% of the LLC membership interests simultaneously with Dr.
Chaudhuri's acquisition of the 49% interest, (b) receipt by Dr. Chaudhuri of
receipt of evidence satisfactory to him that the LLC has
acquired the real
estate (owned in fee) in the Tenet
Transaction
(i.e. Western Medical Center -
Santa Ana, Western Medical Center - Anaheim
and Coastal Community
Hospital and
the medical office buildings, but not the leased Chapman
Hospital and
medical
office building), (c) execution by Dr. Chaudhuri, OC-PIN and Dr. Shah, and by
the Company if initially required, of a customary Operating Agreement for a
California manager-managed limited liability
company reasonably satisfactory to
Dr. Chaudhuri and OC-PIN in which (i) Dr.
Chaudhuri and Dr. Shah have equal
rights of management of the LLC, and (ii)
Dr. Chaudhuri may not sell, syndicate
or otherwise transfer any of his management rights in the LLC without the
consent of the holder(s) of a majority of
the LLC membership interests (although
it is expressly understood that Dr. Chaudhuri may hold title to the LLC
membership interests through an affiliate),
and (d) execution by the Company, as
tenant, of a lease with the LLC,
as landlord, in substantially the form of
Exhibit D. The exercise price shall be placed into escrow
and released
against
delivery of certificates or other satisfactory evidence of transfer to Dr.
Chaudhuri or an affiliate of 49% of the membership interests of the LLC. The
Company and OC-PIN agree to comply with all of the
aforesaid covenants which
may, at Dr. Chaudhuri's election, be specifically enforced as provided in
Section 11.6.
6
<PAGE>
8. CERTAIN
AGREEMENTS RELATED TO
TENET TRANSACTION AND RELATED FINANCING.
The parties have agreed as follows with
respect to the Tenet Transaction and the
proposed $80,000,000 credit facility
("FACILITY") from Company's current Lender,
or other lender agreeable to the parties
("LENDER") related thereto:
(a) The Company and the LLC shall be co-borrowers with respect to
the Facility, with the Company and the LLC each fully
liable for the
entire
amount borrowed thereunder.
(b) The Company
and the LLC will enter
into a mutually
acceptable
inter-borrower and cross-indemnity
agreement.
(c) If
requested by the Lender, the Lender will have a security
interest not only in all of the assets of
the Company and the LLC, but also in
all LLC membership interests and in the master lease from the LLC to the
Company.
9.
CONDITIONS PRECEDENT.
This Agreement, and specifically Dr. Chaudhuri's
and Thomas's obligations hereunder, are expressly conditioned upon Tenet's
acceptance of the restructuring
and other terms set
forth herein, and,
because
Dr. Chaudhuri is rescinding his right to receive any interest
in the Chapman
Hospital real estate, upon Tenet's release of Dr. Chaudhuri's guarantee in
Tenet's favor of the tenant's obligations under the Chapman
Hospital lease. Dr.
Shah shall provide his personal
guarantee of the
tenant's obligations
in place
of that of Dr. Chaudhuri, in a for substantially identical to the form of
guaranty provided by Dr. Chaudhuri to Tenet. The provisions
of this Agreement,
including the exhibits hereto, shall only be effective upon (i)
receipt by Dr.
Chaudhuri of written evidence reasonably satisfactory to him, and executed
by
Tenet, setting forth Tenet's acceptance and release as
described above,
(ii)
receipt by Dr. Chaudhuri of the payment of
$10,000,000
plus accrued
interest
referred to in Section 6, (iii)
receipt by Dr.
Chaudhuri and Thomas of fully
executed originals of the New Notes and New
Warrants, and (iv) execution and
delivery of a mutually agreeable Operating Agreement for the LLC pursuant to
Section 7 above. If all of the foregoing
conditions are not
fully satisfied by
5:00 p.m. on January 31, 2005, Dr.
Chaudhuri shall be entitled to terminate this
Agreement, in which case nothing in this
Agreement, including
all rescissions,
amendments and restructurings, shall be of
any force or effect.
10.
MUTUAL RELEASE. Except with respect to obligations created in or
expressly continued by this Agreement and in the New Warrants and New
Notes,
each of Dr. Chaudhuri and Thomas, on the one hand, and the Company
and OC-PIN,
on the other hand, on behalf of
themselves
and their successors and assigns,
hereby release and discharge the other and the other's representatives,
officers, directors, agents, employees,
attorneys,
successors and assigns
from
any claims, demands, actions, causes of action, losses and
liabilities of any
kind or nature whatsoever that the party may
have, may have had in the past, or
may have in the future, whether known or
unknown, suspected or unsuspected, now
due or contingent, to the full extent that
any such claim, demand, action, cause
of action, loss or liability arises out of or is in any way
related to the
Purchase Agreement, the Convertible Note, the Secured Note, the Stock
Option
Agreement, the Tenet Transaction or OC-PIN's
investment in or other
financial
arrangements with the Company. Each of the parties hereby acknowledges and
agrees that he or it is aware of, has read,
has had explained to him or it by
independent counsel of his or its own
choosing, understands,
and hereby waives
the provisions of California Civil Code
Section 1542, which reads:
7
<PAGE>
A general release does
not extend to claims which the creditor does
not know or suspect to
exist in his favor at the time of executing
the release, which,
if known by him must
materially have
affected
his settlement with the debtor.
Dr. Chaudhuri also agrees to release the individual members of the Medical
Staff, as that term is defined in the
Agreement dated as of January 25, 2005
among the Company, Dr. Chaudhuri, Chapman Medical Center, Inc., Coastal
Communities Hospital, Inc.; WMCA, Inc. and
WMC-SA, Inc. and the Medical Staff of
Western Medical Center - Santa Ana, an
unincorporated
association
(the "STAFF
AGREEMENT"), as more specifically set forth in Section 11 of the Staff
Agreement.
11.
MISCELLANEOUS.
11.1 AMENDMENT.
This Agreement may be modified or
amended only by
mutual written agreement of the parties.
Any such modification or amendment must
be in writing, dated and signed by the
parties and attached to this Agreement.
11.2 BINDING EFFECT. Subject to the foregoing, this Agreement shall
be binding on and shall inure to the
benefit of the parties and their respective
successors and assigns.
11.3 ATTORNEYS' FEES. In any action or dispute, at law or in
equity,
that may arise under or otherwise relate to
this Agreement, the prevailing party
shall be entitled to the award of reasonable attorneys' fees and costs, in
addition to whatever relief the prevailing party may be awarded; provided,
however, that so long as the present Company Board of Directors remains in
place, the parties agree to bear their own fees and
costs in the event of any
dispute.
11.4 VENUE. The
parties agree that Orange County, California shall
be the only proper venue for disputes
related to this Agreement.
11.5 ENTIRE AGREEMENT. This Agreement, along with the New Notes,
New
Warrants and General Continuing Guaranty, and the Purchase Agreement and the
Security Agreement, as amended hereby, represents the entire
understanding and
agreement of the parties regarding its
subject matter, and
supersedes any prior
oral or written agreements, representations, understandings or discussions
between the parties. No other understanding
between the parties shall be binding
on them unless set forth in writing
and signed by the
party against
whom the
understanding is to be enforced.
11.6 SPECIFIC
PERFORMANCE.
The parties
acknowledge
that the LLC
membership interests, the real estate to be acquired by
the LLC, the New Notes
and the New Warrants are unique, and that damages would not be an adequate
remedy for Dr. Chaudhuri and Thomas in the event of the
Company's or
OC-PIN's
failure to perform any of their obligations
hereunder and under the New Warrants
(including, without limitation, its obligation to deliver the Shares if Dr.
Chaudhuri or Thomas elects to exercise his New Warrant). As a result, the
parties agree that this Agreement may be enforced by any party by specific
performance.
8
<PAGE>
11.7 GOVERNING LAW. This Agreement shall be construed in
accordance
with and governed by the laws of the State
of California,
except the
conflicts
of laws provisions that would require the application
of the laws of any other
jurisdiction.
11.8 HEADINGS. The
headings in this
Agreement are intended
solely
for convenience of reference and shall be
given no effect in the construction or
interpretation of this Agreement.
11.9 MEANING OF CERTAIN WORDS. Wherever the context may require,
any
pronouns used in this Agreement shall include the corresponding masculine,
feminine, or neuter forms, and the singular form of nouns shall include the
plural and vice versa.
11.10 NO THIRD-PARTY
BENEFICIARY RIGHTS.
The parties do not intend
to confer and this Agreement shall not be construed to confer any rights or
benefits to any person, firm, corporation
or entity other than the parties.
11.11 NOTICES. All
notices or communications required or permitted
under this Agreement shall be given in
writing and delivered
personally or sent
by United States registered or certified
mail with postage
prepaid and return
receipt requested or by overnight delivery
service (e.g., Federal Express, DHL).
Notice shall be deemed given when sent, if
sent as specified in this Section, or
otherwise deemed given when received. In
each case, notice shall be delivered or
sent to:
IF TO COMPANY, ADDRESSED TO:
Integrated Healthcare Holdings, Inc.
695 Town Center Drive, Suite 260
Costa Mesa, CA 92626
Attention: Chief Executive Officer
IF TO DR. CHAUDHURI OR TO THOMAS, ADDRESSED TO:
c/o Strategic Global Management, Inc.
6800 Indiana Avenue, Suite 130
Riverside, CA 92506
Attention: William E. Thomas, Esq.
IF TO DR. SHAH OR TO OC-PIN, ADDRESSED TO:
c/o Orange County Physicians Investment Network, LLC
2621 S. Bristol Street, Suite 108
Santa Ana, CA 92704
Attention: Anil V. Shah, Manager
11.12 SEVERABILITY. If any provision of this Agreement is
determined
to be illegal or unenforceable, that provision shall be severed from this
Agreement, and such severance shall have no
effect upon the
enforceability of
the remainder of this Agreement.
9
<PAGE>
11.13 WAIVER.
No delay or failure to
require performance of any
provision of this Agreement shall constitute a waiver of that
provision as to
that or any other instance. Any waiver granted by a party must
be in writing to
be effective, and shall apply solely to the
specific instance expressly stated.
11.14 CONFIDENTIALITY. Neither party shall disclose any of the
terms
of this Agreement to any person or entity (other than its attorneys or
accountants) without the prior written
consent of the other
party, unless and
only to the extent such disclosure is
required by law, including the 1933 Act.
11.15 DISPUTE RESOLUTION. In the event of any dispute arising out
of
or relating to this Agreement, such dispute shall be resolved solely and
exclusively by confidential binding
arbitration with the Orange County branch of
JAMS ("JAMS") to be governed by JAMS'
Commercial Rules of
Arbitration in effect
at the time of the commencement of the arbitration
(the "JAMS RULES") and heard
before one arbitrator. The parties shall attempt to mutually select the
arbitrator. In the event they are unable to
mutually agree, the arbitrator shall
be selected by the procedures prescribed by
the JAMS Rules.
11.16 COUNTERPARTS.
This Agreement may be executed in one
or more
counterparts, each of which shall be deemed to
be an original, and all of which
together shall constitute one and the same
instrument.
* * *
[SIGNATURES ON FOLLOWING PAGE]
10
<PAGE>
IN WITNESS
WHEREOF, the parties hereto have caused this Agreement
to be
executed and delivered as of the date first
written above.
THE COMPANY:
INTEGRATED HEALTHCARE HOLDINGS,
INC., a Nevada corporation
By: /s/ Larry
B. Anderson
-------------------------------------
Larry B. Anderson, President
DR. CHAUDHURI:
/s/ Kali P. Chaudhuri
-----------------------------------------
KALI P. CHAUDHURI, M.D.
OC-PIN:
ORANGE COUNTY PHYSICIANS
INVESTMENT NETWORK, LLC, a Nevada
limited liability company
By: /s/ Anil V.
Shah
-------------------------------------
Anil V. Shah, M.D., Manager
For purposes of Sections 3 and 10 only:
I hereby accept the assignment of a portion of Dr.
Chaudhuri's
rights as set
forth in Section 3, and agree to be bound
by the provisions of a
Stock Purchase
Warrant substantially in the form attached hereto as Exhibit B-2, and by
the
provisions of Section 10. Except as
expressly set forth above, I am not a party
to this Agreement and have given no
representations, warranties or assurances to
any person.
THOMAS:
/s/ William E. Thomas
-----------------------------------------
WILLIAM E. THOMAS
For purposes of Sections 2(a) and 9
only:
I hereby agree to the rescission of the
Non-Circumvention Agreement on the terms
and conditions set forth in Section 2(a),
and to providing a personal guarantee
as set forth in Section 9. Except as
expressly set forth above, I am not a party
to this Agreement and have given no
representations, warranties or assurances to
any person.
DR. SHAH
/s/ Anil V. Shah
-----------------------------------------
ANIL V. SHAH, M.D.
11
<PAGE>
Approved as to form:
----------------------------------------
Gregg Amber, Esq. of Rutan & Tucker,
LLP
attorneys for Dr. Chaudhuri
----------------------------------------
Allen Z. Sussman, Esq. of Morrison
&
Foerster, LLP
attorneys for the Company
----------------------------------------
Hari S. Lal, Esq. of The Lal Law Firm,
Inc.
attorneys for Dr. Shah and OC-PIN
12
<PAGE>
EXHIBIT A-1
FORM OF
NON-CONVERTIBLE NOTE
$__________
Costa Mesa, California
January 27, 2005
SECURED PROMISSORY NOTE
FOR VALUE
RECEIVED, the undersigned, INTEGRATED HEALTHCARE HOLDINGS,
INC.,
a Nevada corporation (the "COMPANY"), promises to pay to the order of
Kali P.
Chaudhuri, M.D. ("HOLDER"), at c/o 6800 Indiana Avenue, Suite
130, Riverside,
California 92506, or at such other location as is designated by Holder in
writing hereunder, the aggregate sum of ________________ Dollars ($_______),
bearing simple interest on the unpaid
principal balance of this Note, from the
date of this Note until this Note is paid in full at a rate of
five percent
(5.0%) per annum. Accrued interest shall be computed
based on the actual number
of days elapsed. Interest only shall be payable on the first
Business Day of
each calendar month beginning February 1, 2005. All principal
and accrued but
unpaid interest will be due and payable in full at the Closing of the Tenet
Transaction, or on demand at any time after February 28, 2005 if the Tenet
Transaction has not closed by that date
(the "DUE DATE"). All
payments shall be
made in lawful money of the United States, without offset, deduction, or
counterclaim of any kind.
1.
TERMS. Capitalized terms used herein without definition have the
meanings ascribed to them in the Rescission, Restructuring and Assignment
Agreement of even date herewith by and among the
Company, Holder and certain
other parties thereto.
2 PAYMENTS
AND COMPUTATIONS. All payments on account of indebtedness
evidenced by this Note shall be made not
later than 11:00 A.M. (California time)
on the day when due in lawful money of the United States and shall be first
applied to interest due on the unpaid
principal balance and the remainder to any
principal due. Payments are to be made at such
place as Holder or any legal
holder of this Note may, from time to time, in writing specify, and in the
absence of a specification, at the principal place of business
of Holder as set
forth in the first paragraph of this Note. The Company may pre-pay the full
amount of all principal of and accrued interest under this Note at any time
without premium or penalty.
3.
SECURITY. Repayment of
this Note is secured pursuant to the terms of a
Security Agreement dated September 28, 2004, and is
guarantied by a Continuing
General Guaranty dated January 27, 2005 by
Orange County
Physicians
Investment
Network, LLC.
4.
ATTORNEYS'
FEES. If any action is instituted on this Note, the
successful or prevailing party or parties shall be entitled to recover
reasonable attorneys' fees and other costs incurred in that action or
proceeding, in addition to any other relief
to which the party or parties may be
entitled. Diligence, demand, presentment, notice of dishonor, and protest
are
waived by the Company, and any and all makers, sureties, guarantors, and
endorsers of this Note, and their
successors and assigns. Time is of the essence
for every obligation under this Note.
1
<PAGE>
6.
LAW. This Note shall be construed under the laws of the State of
California, as such laws are applied to
contracts entered
into and performed
entirely within that state by residents
thereof.
7. RULES
OF
CONSTRUCTION/REPRESENTATION. The parties agree that they
are
sophisticated business persons or entities who have had
the opportunity to
be
represented by counsel during the negotiation and execution of this Note
and,
therefore, waive the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or
other document will
be construed against the party drafting
such agreement or document.
8.
DISPUTE RESOLUTION. In the event of any dispute arising out of or
relating to this Note, such dispute shall be resolved
solely and exclusively by
confidential binding arbitration with the
Orange County branch of JAMS ("JAMS")
to be governed by JAMS' Commercial Rules of
Arbitration in effect at the time of
the commencement of the arbitration (the "JAMS RULES") and heard before one
arbitrator. The parties shall attempt to
mutually select the arbitrator. In the
event they are unable to mutually agree,
the arbitrator shall be selected by the
procedures prescribed by the JAMS Rules. Each party shall bear its own
attorneys' fees, expert witness fees, and costs
incurred in connection with any
arbitration.
IN WITNESS
WHEREOF, the Company has executed and delivered this Note as of
the day and year and at the place first
above written.
INTEGRATED HEALTHCARE HOLDINGS, INC.
By:
--------------------------------------
Larry B. Anderson, President
2
<PAGE>
EXHIBIT A-2
FORM OF
NON-CONVERTIBLE NOTE
$__________
Costa Mesa, California
January 27, 2005
SECURED PROMISSORY NOTE
FOR VALUE
RECEIVED, the undersigned, INTEGRATED HEALTHCARE HOLDINGS,
INC.,
a Nevada corporation (the "COMPANY"),
promises to pay to the order of William E.
Thomas ("HOLDER"), at c/o 6800 Indiana
Avenue, Suite 130, Riverside, California
92506, or at such other location as is designated by Holder in writing
hereunder, the aggregate sum of
________________
Dollars ($_______),
bearing
simple interest on the unpaid principal balance of this Note, from the
date of
this Note until this Note is paid in full
at a rate of five
percent (5.0%) per
annum. Accrued interest shall be computed based on the actual number of
days
elapsed. Interest only shall be payable on the first Business Day of each
calendar month beginning February 1, 2005. All principal
and accrued but unpaid
interest will be due and payable in full at the Closing of the Tenet
Transaction, or on demand at any time after February 28, 2005 if the Tenet
Transaction has not closed by that date
(the "DUE DATE"). All
payments shall be
made in lawful money of the United States, without offset, deduction, or
counterclaim of any kind.
1.
TERMS. Capitalized terms used herein without definition have the
meanings ascribed to them in the Rescission, Restructuring and Assignment
Agreement of even date herewith by and among the
Company, Holder and certain
other parties thereto.
2 PAYMENTS
AND COMPUTATIONS. All payments on account of indebtedness
evidenced by this Note shall be made not
later than 11:00 A.M. (California time)
on the day when due in lawful money of the United States and shall be first
applied to interest due on the unpaid
principal balance and the remainder to any
principal due. Payments are to be made at such
place as Holder or any legal
holder of this Note may, from time to time, in writing specify, and in the
absence of a specification, at the principal place of business
of Holder as set
forth in the first paragraph of this Note. The Company may pre-pay the full
amount of all principal of and accrued interest under this Note at any time
without premium or penalty.
3.
SECURITY. Repayment of
this Note is secured pursuant to the terms of a
Security Agreement dated September 28, 2004, and is
guarantied by a Continuing
General Guaranty dated January 27, 2005 by
Orange County
Physicians
Investment
Network, LLC.
4.
ATTORNEYS'
FEES. If any action is instituted on this Note, the
successful or prevailing party or parties shall be entitled to recover
reasonable attorneys' fees and other costs incurred in that action or
proceeding, in addition to any other relief
to which the party or parties may be
entitled. Diligence, demand, presentment, notice of dishonor, and protest
are
waived by the Company, and any and all makers, sureties, guarantors, and
endorsers of this Note, and their
successors and assigns. Time is of the essence
for every obligation under this Note.
1
<PAGE>
6.
LAW. This Note shall be construed under the laws of the State of
California, as such laws are applied to
contracts entered
into and performed
entirely within that state by residents
thereof.
7. RULES
OF
CONSTRUCTION/REPRESENTATION. The parties agree that they
are
sophisticated business persons or entities who have had
the opportunity to
be
represented by counsel during the negotiation and execution of this Note
and,
therefore, waive the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or
other document will
be construed against the party drafting
such agreement or document.
8.
DISPUTE RESOLUTION. In the event of any dispute arising out of or
relating to this Note, such dispute shall be resolved
solely and exclusively by
confidential binding arbitration with the
Orange County branch of JAMS ("JAMS")
to be governed by JAMS' Commercial Rules of
Arbitration in effect at the time of
the commencement of the arbitration (the "JAMS RULES") and heard before one
arbitrator. The parties shall attempt to
mutually select the arbitrator. In the
event they are unable to mutually agree,
the arbitrator shall be selected by the
procedures prescribed by the JAMS Rules. Each party shall bear its own
attorneys' fees, expert witness fees, and costs
incurred in connection with any
arbitration.
IN WITNESS
WHEREOF, the Company has executed and delivered this Note as of
the day and year and at the place first
above written.
INTEGRATED HEALTHCARE HOLDINGS, INC.
By:
--------------------------------------
Larry B. Anderson, President
2
<PAGE>
EXHIBIT B-1
FORM OF
STOCK PURCHASE WARRANT
60,000,000 Shares
January 27, 2005
This
certifies that, for good and valuable consideration, receipt of
which
is hereby acknowledged, Kali P. Chaudhuri, M.D. (the "HOLDER") is entitled
to
purchase, subject to the terms and
conditions of this Warrant, from Integrated
Healthcare Holdings, Inc, a Nevada corporation (the
"COMPANY"), Sixty
Million
(60,000,000) shares of the Company's
common stock (the
"SHARES") in accordance
with Section 3 during the period
commencing
on the second
anniversary
of the
date hereof (the "COMMENCEMENT DATE") and ending at 5:00 p.m.
California time,
on the date which is three and one-half (3 1/2) years from the
date hereof (the
"EXPIRATION DATE"), at which time this Warrant will expire and become void
unless earlier terminated as provided
herein. Notwithstanding the foregoing,
this Warrant may not be exercised in an
amount that would exceed, when added to
the number of shares of common stock of the
Company previously
acquired by the
Holder by virtue of exercise of this Warrant (or any replacement Warrant),
twenty percent (20%) of the total number of
outstanding shares of
capital stock
of the Company on a Fully-Diluted basis on the date of exercise. Capitalized
terms used herein without definition have the meanings
ascribed to them in
the
Rescission, Restructuring and Assignment
Agreement of even date herewith by and
among the Company, the Holder and certain
other parties thereto.
1. VESTING
AND EXERCISE PRICE.
(a) The right to
exercise this
Warrant shall fully vest on the
Commencement Date.
(b) The exercise or purchase price for the first 34,538,153 Shares
purchased
upon exercise of this Warrant shall be $0.003125 per Share,
and
the
exercise or purchase
price for the
remainder of the
Shares shall be
$0.078 per
Share if exercised
between January 27, 2007 and July 26, 2007,
$0.11 per
Share if exercised
between July 27, 2007
and January 26, 2008,
and $0.15
thereafter,
all subject to
adjustment as provided in Section 2
(the
"EXERCISE PRICE").
2.
ANTI-DILUTION PROVISIONS. The Exercise Price in effect at
any time and
the number of Shares purchasable upon the exercise of this Option shall be
subject to adjustment from time to time upon the happening of any of the
following events:
(a) If at any time the Company subdivides its outstanding shares
of
Common
Stock into a greater number of shares, the Exercise Price in
effect
immediately prior to such subdivision shall be proportionately
reduced. If
at any
time the outstanding
shares of Common
Stock of the
Company are
combined
into a smaller
number of shares,
the Exercise
Price in effect
immediately prior to such combination shall be proportionately
increased.
1
<PAGE>
(b) Whenever
the Exercise Price payable upon exercise of this
Warrant
is adjusted pursuant to this Section 2, the number of Shares
purchasable upon
exercise hereof simultaneously shall be adjusted by
multiplying the
number of Shares issuable immediately prior to such
adjustment
by the Exercise Price in effect immediately prior to such
adjustment
and dividing the product so obtained by the Exercise Price, as
adjusted.
(c) the Company
shall give notice to the Holder of any event or
transaction that
results in an adjustment in the Exercise Price, within
ten (10) business days
thereof, at the
Holder's address as it
appears on
the books
of the Company,
including a computation of such adjustment and
any
adjustment
in the number of
Shares for which the Holder may exercise
this
Warrant and any further information as shall be necessary
to confirm
the
computation of such adjustments.
(d) So long as this Warrant is outstanding, if (i) the Company pays
any
dividend or makes any
distribution upon the
Common Stock,
(ii) the
Company
offers to the
holders of the Common
Stock for subscription or
purchase
by them any
share of any
class of capital stock or any other
rights
or (iii) any capital reorganization of the Company,
reclassification of
the capital
stock of the Company, consolidation,
merger or
other business
combination of the
Company with or into another
entity,
sale, lease or
transfer of all or substantially all of the assets
of the
Company to another entity, or voluntary or involuntary
dissolution,
liquidation or winding
up of the Company
shall be effected,
then in any
such case,
the Company shall
cause to be mailed by certified mail to the
Holder,
at least ten (10) days
prior to the date
specified in clause (x)
or (y)
below, as the case may be, a notice containing a brief description
of the
proposed action and stating the date on which (x) a record
date
shall be
established
for the purpose of
such dividend,
distribution or
rights
offering
or (y) such reclassification,
reorganization,
consolidation, merger,
conveyance,
sale, lease, transfer,
dissolution,
liquidation or winding
up shall take place and the date, if any to be
fixed, as
of which the holders of Common Stock or other securities shall
receive
cash or other property
deliverable
upon such reclassification,
reorganization, consolidation,
merger,
conveyance,
dissolution,
liquidation or winding up.
3.
EXERCISE AND PAYMENT.
3.1 CASH EXERCISE. At
any time after the
Commencement Date,
this
Warrant may be exercised, in whole or in part, from time to
time by the Holder,
during the term hereof, by surrender of this Warrant and
the Notice of Exercise
annexed hereto duly completed and executed by the
Holder to the Company at the
principal executive offices of the Company,
together with payment
in the amount
of the Exercise Price then in effect, as designated in the Notice of
Exercise.
Payment may be in cash or by check payable
to the order of the Company.
3.2 NET ISSUANCE. In lieu of payment of the Exercise Price
described
in Section 3.1, the Holder may elect to
receive, without the payment by the
Holder of any additional consideration, Shares equal to the value of this
Warrant or any portion hereof by the surrender of this Warrant or such
portion
to the Company, with the net issue election notice annexed hereto (the "NET
ISSUANCE ELECTION NOTICE") duly executed, at the office of the Company.
Thereupon, the Company shall issue to the Holder such
number of fully paid and
nonassessable Shares as is computed using
the following formula:
2
<PAGE>
where: X = Y (A-B)
-------
A
X =
the
number of Shares to be
issued to the Holder
pursuant to
this Section 3.
Y =
the
number of Shares
covered by this Warrant in respect of
which the net
issuance election is made pursuant to this
Section 3.
A =
the
fair market value of one Share, as determined in
accordance with the provisions of this Section 3.
B =
the
Exercise Price in effect under this Warrant at the time
the net issuance election is made pursuant to this Section 3.
For purposes of this Section 3, the "fair
market value" per Share shall mean:
i. If the class of Shares is traded on a national securities
exchange or is listed on the Nasdaq National Market (the "NNM")
or other over-the-counter quotation system, the fair market
value
shall be the last reported sale price of a Share on such
exchange
or on the NNM or other
over-the-counter
quotation system on the
last business day
before the effective
date of exercise of
the
net issuance election or if no such sale is made on such day,
the
mean of the closing
bid and asked
prices for such day on such
exchange, the NNM or over-the-counter quotation system; and
ii. If the class of Shares is not so listed and bid and ask
prices are not reported, the fair market value shall be the
price
per Share which the Company could obtain from a willing buyer
for
Shares sold by the Company, as such price shall be determined
in
good faith by the Company's Board of Directors.
3.3 NO PARTIAL
EXERCISE. This
Warrant, if exercised,
may only be
exercised as to the full number of Shares
that may be permitted to be purchased
at the time of exercise. No partial
exercises are permitted.
4.
DELIVERY OF CERTIFICATES. Within five (5) business days after
exercise,
in whole or in part, of this Warrant, the
Company shall issue in the name of and
deliver to the Holder, a certificate or certificates for the number of fully
paid and nonassessable Shares which the Holder shall have requested in the
Notice of Exercise or Net Issuance Election
Notice. If this Warrant is exercised
in part, the Company shall deliver to the Holder a new Warrant for the
unexercised portion of this Warrant at the
time of delivery of such certificate
or certificates.
5. NO
FRACTIONAL
SHARES. No fractional Shares or scrip representing
fractional Shares will be issued upon
exercise of this Warrant. If upon any
exercise of this Warrant a fraction of a
Share results, the Company will pay the
Holder the difference between the cash value of the
fractional
Share and the
portion of the Exercise Price allocable to
the fractional Share.
3
<PAGE>
6.
CHARGES, TAXES AND EXPENSES. The Holder shall pay all transfer
taxes or
other incidental charges, if any, in connection
with the transfer of the Shares
purchased pursuant to the exercise hereof
from the Company to the Holder.
7. LOSS,
THEFT, DESTRUCTION OR
MUTILATION OF WARRANT. Upon receipt by the
Company of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant, and in case of loss, theft or
destruction, of indemnity or security
reasonably
satisfactory to the
Company,
and upon reimbursement to the Company of all reasonable expenses incidental
thereto, and upon surrender and
cancellation of this Warrant, if mutilated, the
Company will make and deliver a new Warrant of like
tenor and dated as of such
cancellation, in lieu of this Warrant.
8. RIGHTS
AS SHAREHOLDER.
Prior to exercise of
this Warrant, the
Holder
shall not be entitled to any rights as a
shareholder of the Company with respect
to the Shares, including (without limitation) the right to vote such Shares,
receive dividends or other distributions
thereon, or be
notified of Shareholder
meetings, and the Holder shall not be entitled to any notice or other
communication concerning the business or
affairs of the Company. However, in the
event of any taking by the Company of a record of the holders of any class of
securities for the purpose of determining
the holders
thereof who are
entitled
to receive any dividend (other than a cash
dividend) or other distribution, any
right to subscribe for, purchase or otherwise acquire any Common Stock or
any
other securities or property,
or to receive any
other right, the Company shall
mail to each Holder of this Warrant, at least ten (10) days prior to
the date
specified therein, a notice specifying the date on
which any such record is to
be taken for the purpose of such dividend,
distribution or right, and the amount
and character of such dividend,
distribution or right.
9.
RESTRICTED SECURITIES. The Holder understands that this Warrant and
the
Shares purchasable hereunder constitute "restricted securities" under the
federal securities laws inasmuch as they are, or will be,
acquired from the
Company in transactions not involving a
public offering and accordingly may not,
under such laws and applicable regulations, be resold or transferred without
registration under the Securities Act of 1933
(the "1933 ACT") or an applicable
exemption from such registration.
In this connection,
the Holder
acknowledges
that Rule 144 of the Securities and
Exchange Commission
(the "SEC") is not now,
and may not in the future be, available for
resale of the Warrant and the Shares
purchasable hereunder. Unless the Shares
are subsequently registered, the Holder
further acknowledges that the securities legend on Exhibit A to the Notice
of
Exercise attached hereto shall be placed on
any Shares issued to the Holder upon
exercise of this Warrant.
10. CERTIFICATION OF INVESTMENT
PURPOSE. Unless a current registration
statement under the 1933 Act is in effect
with respect to the
securities to be
issued upon exercise of this Warrant,
the Holder
covenants and agrees
that, at
the time of exercise hereof, he will deliver to the Company a written
certification executed by the Holder that
the securities acquired by such Holder
upon exercise hereof are for the account of such Holder and acquired for
investment purposes only and that such
securities are not
acquired with a view
to, or for sale in connection with, any
distribution thereof.
4
<PAGE>
11.
TRANSFERABILITY.
This Warrant
shall be transferable by the Holder
subject to compliance with law.
12.
MISCELLANEOUS.
12.1 CONSTRUCTION.
Unless the context indicates otherwise, the term
"Holder" shall include any transferee or transferees of this Warrant,
and the
term "Warrant" shall include any and all
warrants outstanding
pursuant to this
Agreement, including those evidenced by a certificate or
certificates
issued
upon division, exchange, substitution or
transfer.
12.2 RESTRICTIONS. By
receipt of this Warrant, the Holder makes the
same representations with respect to the acquisition of this Warrant as the
Holder is required to make upon the
exercise of this Warrant and acquisition of
the Shares purchasable hereunder as set forth in the Form
of Investment Letter
attached as Exhibit A to the Notice of
Exercise attached hereto.
12.3 NOTICES. Unless
otherwise provided, any notice required or
permitted under this Warrant shall be given in writing and shall be deemed
effectively given upon personal delivery to the party to be
notified or three
(3) days following deposit with the United States
Post Office, by registered or
certified mail, postage prepaid and addressed to the party
to be notified (or
one (1) day following timely deposit with a reputable
overnight courier with
next day delivery instructions), or upon confirmation of receipt by
the sender
of any notice by facsimile transmission, at the address indicated below or at
such other address as such party may
designate by ten (10) days' advance written
notice to the other parties.
If to the
Company, addressed to: Integrated
Healthcare Holdings, Inc.
695 Town Center Drive, Suite 260
Costa Mesa, CA 92626
Attention: Chief Executive Officer
If to the
Holder, addressed to: c/o
Strategic Global Management, Inc.
6800 Indiana Avenue, Suite 130
Riverside, CA 92506
Attention: William E. Thomas, Esq.
12.4 GOVERNING LAW.
This Warrant shall be governed by and construed
under the laws of the State of California as applied to agreements among
California residents entered into and to be performed entirely within
California.
12.5 ENTIRE AGREEMENT.
This Warrant, the exhibits and schedules
hereto, and the documents referred to herein, constitute the entire
agreement
and understanding of the parties hereto with respect to the subject
matter
hereof, and supersede all prior and contemporaneous agreements and
understandings, whether oral or written,
between the parties hereto with respect
to the subject matter hereof.
5
<PAGE>
12.6 BINDING
EFFECT. This Warrant and the various rights and
obligations arising hereunder shall inure to
the benefit of and be binding upon
the Company and its successors and assigns, and Holder and its successors
and
assigns.
12.7 WAIVER;
CONSENT. This Warrant may not be changed,
amended,
terminated, augmented, rescinded or discharged (other
than by performance), in
whole or in part, except by a writing executed by the parties
hereto, and no
waiver of any of the provisions or conditions of this Warrant or any of the
rights of a party hereto shall be effective
or binding unless such
waiver shall
be in writing and signed by the party claimed to have given or consented
thereto.
12.8 SEVERABILITY.
If one or more
provisions
of this Warrant
are
held to be unenforceable under applicable law, such
provision shall be excluded
from this Warrant and the balance of the
Warrant shall be interpreted as if such
provision were so excluded and the balance
shall be enforceable
in accordance
with its terms.
12.9 DISPUTE RESOLUTION. In the event of any dispute
arising out of
or relating to this Warrant, such dispute shall be resolved solely and
exclusively by confidential binding
arbitration with the Orange County branch of
JAMS ("JAMS") to be governed by JAMS'
Commercial Rules of
Arbitration in effect
at the time of the commencement of the arbitration
(the "JAMS RULES") and heard
before one arbitrator. The parties shall attempt to mutually select the
arbitrator. In the event they are unable to
mutually agree, the arbitrator shall
be selected by the procedures prescribed by the JAMS Rules. Each party shall
bear its own attorneys' fees, expert witness fees, and costs incurred in
connection with any arbitration.
IN WITNESS
WHEREOF, the parties
have executed this Warrant as of the date
first above written.
"HOLDER":
-----------------------------------------
KALI P. CHAUDHURI, M.D., an individual
"COMPANY":
INTEGRATED HEALTHCARE HOLDINGS,
INC., a Nevada corporation
By:
--------------------------------------
Larry B. Anderson, President
6
<PAGE>
NOTICE OF EXERCISE
To: INTEGRATED HEALTHCARE HOLDINGS,
INC.
The undersigned hereby
elects to purchase
_____________ shares
of
_________ Stock (the "Shares") of
Integrated Healthcare Holdings, Inc., a Nevada
corporation (the "Company") pursuant to the terms of the
attached Warrant,
and
tenders herewith payment of the purchase price pursuant to the terms of the
Warrant.
Attached as
Exhibit A is an investment representation letter
addressed to the Company and executed by
the undersigned as
required by Section
10 of the Warrant.
Please issue
certificates
representing the
Common Stock purchased
hereunder in the names and in the
denominations
indicated on Exhibit A attached
hereto.
Please issue a new
Warrant for the unexercised portion of the
attached Warrant, if any, in the name of
the undersigned.
Dated:
--------------------------------
-----------------------------------
Name:
-----------------------------
Title:
-----------------------------
<PAGE>
NET ISSUANCE ELECTION NOTICE
To: INTEGRATED HEALTHCARE HOLDINGS,
INC.
Date:_____________
The
undersigned hereby elects under Section 3.2 of the attached Warrant
to
surrender the right to purchase
___________
shares of ___________ Stock (the
"Shares") pursuant to the attached Warrant.
The Certificate(s) for the Shares
issuable upon such net issuance election shall be issued in the name of
the
undersigned or as otherwise indicated
below.
Attached
as Exhibit A is an investment representation letter addressed
to
the Company and executed by the undersigned as required by Section 10 of
the
Warrant.
Please
issue certificates
representing the Shares purchased hereunder in
the names and in the denominations
indicated on Exhibit A attached hereto.
Please
issue a new Warrant
for the unexercised
portion of the
attached
Warrant, if any, in the name of the
undersigned.
---------------------------
Signature
---------------------------
Name for Registration
---------------------------
Mailing Address
<PAGE>
EXHIBIT A
To: INTEGRATED HEALTHCARE HOLDINGS,
INC.
In
connection with the purchase by the undersigned of _________
shares of
Common Stock (the "SHARES") of Integrated
Healthcare
Holdings, Inc., a Nevada
corporation (the "COMPANY"), upon exercise of that certain
Warrant dated as of
January 27, 2005, the undersigned hereby
represents and warrants as follows:
The Shares
to be received by the undersigned upon exercise of the Warrant
are being acquired for his own account,
not as a nominee or
agent, and not with
a view to resale or distribution of any
part thereof, and the undersigned has no
present intention of selling, granting any participation in, or otherwise
distributing the same. The undersigned
further represents
that he does not have
any contract, undertaking, agreement or arrangement with any person to sell,
transfer or grant participation to such person or to any third
person, with
respect to the Shares. The undersigned believes he has received all the
information he considers necessary or appropriate for deciding whether to
purchase the Shares.
The
undersigned
understands
that the Shares are characterized as
"restricted securities" under the federal
securities laws
inasmuch as they are
being acquired from the Company in
transactions not
involving a public offering
and that under such laws and applicable regulations such securities may be
resold without registration under the Securities Act of 1933,
as amended (the
"ACT"), only in certain limited circumstances. In this connection, the
undersigned represents that he is familiar with SEC Rule 144, as presently
in
effect, and understands the resale
limitations imposed thereby and by the Act.
Without in
any way limiting
the representations set forth above, the
undersigned agrees not to make any disposition of all or any portion of the
Shares unless and until:
There is
then in effect a
registration statement
under the Act
covering
such proposed disposition and such disposition is made in accordance
with such
registration statement; or
(i)
The undersigned has notified the Company of the proposed
disposition and shall have furnished the Company with a detailed
statement
of the
circumstances surrounding the proposed disposition, and
(ii) if requested, the undersigned has furnished the Company with
an
opinion of
counsel, reasonably satisfactory to the Company that such
disposition will not
require registration
of such shares under
the Act.
The
Company will not require an opinion of counsel for sales made
pursuant
to Rule
144 except in unusual circumstances.
The
undersigned understands the instruments evidencing the Shares may
bear
a legend similar to the following:
<PAGE>
THE
SECURITIES REPRESENTED
BY THIS CERTIFICATE
HAVE NOT BEEN
REGISTERED
UNDER THE SECURITIES ACT OF 1933; THEY HAVE BEEN ACQUIRED BY THE HOLDER FOR
INVESTMENT AND MAY NOT BE PLEDGED,
HYPOTHECATED, SOLD,
TRANSFERRED OR OTHERWISE
DISPOSED OF EXCEPT AS MAY BE AUTHORIZED
UNDER THE SECURITIES ACT OF 1933, AND
THE RULES AND REGULATIONS PROMULGATED
THEREUNDER.
Dated:
--------------------------------
------------------------------------
Name:
-----------------------------
Title:
-----------------------------
<PAGE>
EXHIBIT B-2
FORM OF
STOCK PURCHASE WARRANT
14,700,000 Shares
January 27, 2005
This
certifies that, for good and valuable consideration, receipt of
which
is hereby acknowledged, William E. Thomas (the "HOLDER") is entitled to
purchase, subject to the terms and
conditions of this Warrant, from Integrated
Healthcare Holdings, Inc, a Nevada corporation (the "COMPANY"), Fourteen
Million, Seven Hundred Thousand (14,700,000) shares of the Company's
common
stock (the "SHARES") in accordance
with Section 3 during
the period
commencing
on the second anniversary of the date hereof (the "COMMENCEMENT DATE") and
ending at 5:00 p.m. California time, on the date which
is three and one-half (3
1/2) years from the date hereof (the "EXPIRATION DATE"), at which time this
Warrant will expire and become void unless earlier terminated as provided
herein. Notwithstanding the foregoing,
this Warrant may not
be exercised in an
amount that would exceed, when added to the number of shares
of common stock of
the Company previously acquired by the Holder by virtue of
exercise of this
Warrant (or any replacement Warrant), four
and nine-tenths percent (4.9%) of the
total number of outstanding shares of capital stock of the Company on a
Fully-Diluted basis on the date of exercise. Capitalized terms used herein
without definition have the meanings ascribed to them in the Rescission,
Restructuring and Assignment Agreement of even date herewith by
and among the
Company, the Holder and certain other
parties thereto.
1. VESTING
AND EXERCISE PRICE.
(a) The right to
exercise this
Warrant shall fully vest on the
Commencement Date.
(b) The exercise or purchase price for the first 8,461,847 Shares
purchased
upon exercise of this Warrant shall be $0.003125 per Share,
and
the
exercise or purchase
price for the
remainder of the
Shares shall be
$0.078 per
Share if exercised
between January 27, 2007 and July 26, 2007,
$0.11 per
Share if exercised
between July 27, 2007
and January 26, 2008,
and $0.15
thereafter,
all subject to
adjustment as provided in Section 2
(the
"EXERCISE PRICE").
2.
ANTI-DILUTION PROVISIONS. The Exercise Price in effect at
any time and
the number of Shares purchasable upon the exercise of this Option shall be
subject to adjustment from time to time upon the happening of any of the
following events:
(a) If at any time the Company subdivides its outstanding shares
of
Common
Stock into a greater number of shares, the Exercise Price in
effect
immediately prior to such subdivision shall be proportionately
reduced. If
at any
time the outstanding
shares of Common
Stock of the
Company are
combined
into a smaller
number of shares,
the Exercise
Price in effect
immediately prior to such combination shall be proportionately
increased.
1
<PAGE>
(b) Whenever
the Exercise Price payable upon exercise of this
Warrant
is adjusted pursuant to this Section 2, the number of Shares
purchasable upon
exercise hereof simultaneously shall be adjusted by
multiplying the
number of Shares issuable immediately prior to such
adjustment
by the Exercise Price in effect immediately prior to such
adjustment
and dividing the product so obtained by the Exercise Price, as
adjusted.
(c) the Company
shall give notice to the Holder of any event or
transaction that
results in an adjustment in the Exercise Price, within
ten (10)
business days thereof,
at the Holder's
address as it appears on
the books
of the Company,
including a computation of such adjustment and
any
adjustment
in the number of
Shares for which the Holder may exercise
this
Warrant and any further information as shall be necessary
to confirm
the
computation of such adjustments.
(d) So long as this Warrant is outstanding, if (i) the Company pays
any
dividend or makes any
distribution upon the
Common Stock,
(ii) the
Company
offers to the
holders of the Common
Stock for subscription or
purchase
by them any
share of any
class of capital stock or any other
rights
or (iii) any capital reorganization of the Company,
reclassification of
the capital
stock of the Company, consolidation,
merger or
other business
combination of the
Company with or into another
entity,
sale, lease or
transfer of all or substantially all of the assets
of the
Company to another entity, or voluntary or involuntary
dissolution,
liquidation or winding
up of the Company
shall be effected,
then in any
such case,
the Company shall
cause to be mailed by certified mail to the
Holder,
at least ten (10) days
prior to the date
specified in clause (x)
or (y)
below, as the case may be, a notice containing a brief description
of the
proposed action and stating the date on which (x) a record
date
shall be
established
for the purpose of
such dividend,
distribution or
rights
offering
or (y) such reclassification,
reorganization,
consolidation, merger,
conveyance,
sale, lease, transfer,
dissolution,
liquidation or winding
up shall take place and the date, if any to be
fixed, as
of which the holders of Common Stock or other securities shall
receive
cash or other property
deliverable
upon such reclassification,
reorganization, consolidation,
merger,
conveyance,
dissolution,
liquidation or winding up.
3.
EXERCISE AND PAYMENT.
3.1 CASH EXERCISE. At
any time after the
Commencement Date,
this
Warrant may be exercised, in whole or in part, from time to
time by the Holder,
during the term hereof, by surrender of this Warrant and
the Notice of Exercise
annexed hereto duly completed and executed by the
Holder to the Company at the
principal executive offices of the Company,
together with payment
in the amount
of the Exercise Price then in effect, as designated in the Notice of
Exercise.
Payment may be in cash or by check payable
to the order of the Company.
3.2 NET ISSUANCE. In lieu of payment of the Exercise Price
described
in Section 3.1, the Holder may elect to
receive, without the payment by the
Holder of any additional consideration, Shares equal to the value of this
Warrant or any portion hereof by the surrender of this Warrant or such
portion
to the Company, with the net issue election notice annexed hereto (the "NET
ISSUANCE ELECTION NOTICE") duly executed, at the office of the Company.
Thereupon, the Company shall issue to the Holder such
number of fully paid and
nonassessable Shares as is computed using
the following formula:
2
<PAGE>
where: X = Y (A-B)
-------
A
X =
the
number of Shares to be
issued to the Holder
pursuant to
this Section 3.
Y =
the
number of Shares
covered by this Warrant in respect of
which the net
issuance election is made pursuant to this
Section 3.
A =
the
fair market value of one Share, as determined in
accordance with the provisions of this Section 3.
B =
the
Exercise Price in effect under this Warrant at the time
the net issuance election is made pursuant to this Section 3.
For purposes of this Section 3, the "fair
market value" per Share shall mean:
i. If the class of Shares is traded on a national securities
exchange or is listed on the Nasdaq National Market (the "NNM")
or other over-the-counter quotation system, the fair market
value
shall be the last reported sale price of a Share on such
exchange
or on the NNM or other
over-the-counter
quotation system on the
last business day
before the effective
date of exercise of
the
net issuance election or if no such sale is made on such day,
the
mean of the closing
bid and asked
prices for such day on such
exchange, the NNM or over-the-counter quotation system; and
ii. If the class of Shares is not so listed and bid and ask
prices are not reported, the fair market value shall be the
price
per Share which the Company could obtain from a willing buyer
for
Shares sold by the Company, as such price shall be determined
in
good faith by the Company's Board of Directors.
3.3 NO PARTIAL
EXERCISE. This
Warrant, if exercised,
may only be
exercised as to the full number of Shares
that may be permitted to be purchased
at the time of exercise. No partial
exercises are permitted.
4.
DELIVERY OF CERTIFICATES. Within five (5) business days after
exercise,
in whole or in part, of this Warrant, the
Company shall issue in the name of and
deliver to the Holder, a certificate or certificates for the number of fully
paid and nonassessable Shares which the Holder shall have requested in the
Notice of Exercise or Net Issuance Election
Notice. If this Warrant is exercised
in part, the Company shall deliver to the Holder a new Warrant for the
unexercised portion of this Warrant at the
time of delivery of such certificate
or certificates.
5. NO
FRACTIONAL
SHARES. No fractional Shares or scrip representing
fractional Shares will be issued upon
exercise of this Warrant. If upon any
exercise of this Warrant a fraction of a
Share results, the Company will pay the
Holder the difference between the cash value of the
fractional
Share and the
portion of the Exercise Price allocable to
the fractional Share.
3
<PAGE>
6.
CHARGES, TAXES AND EXPENSES. The Holder shall pay all transfer
taxes or
other incidental charges, if any, in connection
with the transfer of the Shares
purchased pursuant to the exercise hereof
from the Company to the Holder.
7. LOSS,
THEFT, DESTRUCTION OR
MUTILATION OF WARRANT. Upon receipt by the
Company of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant, and in case of loss, theft or
destruction, of indemnity or security
reasonably
satisfactory to the
Company,
and upon reimbursement to the Company of all reasonable expenses incidental
thereto, and upon surrender and
cancellation of this Warrant, if mutilated, the
Company will make and deliver a new Warrant of like
tenor and dated as of such
cancellation, in lieu of this Warrant.
8. RIGHTS
AS SHAREHOLDER.
Prior to exercise of
this Warrant, the
Holder
shall not be entitled to any rights as a
shareholder of the Company with respect
to the Shares, including (without limitation) the right to vote such Shares,
receive dividends or other distributions
thereon, or be
notified of Shareholder
meetings, and the Holder shall not be entitled to any notice or other
communication concerning the business or
affairs of the Company. However, in the
event of any taking by the Company of a record of the holders of any class of
securities for the purpose of determining
the holders
thereof who are
entitled
to receive any dividend (other than a cash
dividend) or other distribution, any
right to subscribe for, purchase or otherwise acquire any Common Stock or
any
other securities or property,
or to receive any
other right, the Company shall
mail to each Holder of this Warrant, at least ten (10) days prior to
the date
specified therein, a notice specifying the date on
which any such record is to
be taken for the purpose of such dividend,
distribution or right, and the amount
and character of such dividend,
distribution or right.
9.
RESTRICTED SECURITIES. The Holder understands that this Warrant and
the
Shares purchasable hereunder constitute "restricted securities" under the
federal securities laws inasmuch as they are, or will be,
acquired from the
Company in transactions not involving a
public offering and accordingly may not,
under such laws and applicable regulations, be resold or transferred without
registration under the Securities Act of 1933
(the "1933 ACT") or an applicable
exemption from such registration.
In this connection,
the Holder
acknowledges
that Rule 144 of the Securities and
Exchange Commission
(the "SEC") is not now,
and may not in the future be, available for
resale of the Warrant and the Shares
purchasable hereunder. Unless the Shares
are subsequently registered, the Holder
further acknowledges that the securities legend on Exhibit A to the Notice
of
Exercise attached hereto shall be placed on
any Shares issued to the Holder upon
exercise of this Warrant.
10.
CERTIFICATION OF
INVESTMENT PURPOSE.
Unless a current
registration
statement under the 1933 Act is in effect
with respect to the
securities to be
issued upon exercise of this Warrant,
the Holder
covenants and agrees
that, at
the time of exercise hereof, he will deliver to the Company a written
certification executed by the Holder that
the securities acquired by such Holder
upon exercise hereof are for the account of such Holder and acquired for
investment purposes only and that such
securities are not
acquired with a view
to, or for sale in connection with, any
distribution thereof.
4
<PAGE>
11.
TRANSFERABILITY.
This Warrant
shall be transferable by the Holder
subject to compliance with law.
12.
MISCELLANEOUS.
12.1 CONSTRUCTION.
Unless the context indicates otherwise, the term
"Holder" shall include any transferee or transferees of this Warrant,
and the
term "Warrant" shall include any and all
warrants outstanding
pursuant to this
Agreement, including those evidenced by a certificate or
certificates
issued
upon division, exchange, substitution or
transfer.
12.2 RESTRICTIONS. By
receipt of this Warrant, the Holder makes the
same representations with respect to the acquisition of this Warrant as the
Holder is required to make upon the
exercise of this Warrant and acquisition of
the Shares purchasable hereunder as set forth in the Form
of Investment Letter
attached as Exhibit A to the Notice of
Exercise attached hereto.
12.3 NOTICES. Unless
otherwise provided, any notice required or
permitted under this Warrant shall be given in writing and shall be deemed
effectively given upon personal delivery to the party to be
notified or three
(3) days following deposit with the United States
Post Office, by registered or
certified mail, postage prepaid and addressed to the party
to be notified (or
one (1) day following timely deposit with a reputable
overnight courier with
next day delivery instructions), or upon confirmation of receipt by
the sender
of any notice by facsimile transmission, at the address indicated below or at
such other address as such party may
designate by ten (10) days' advance written
notice to the other parties.
If to the Company, addressed to:
Integrated Healthcare Holdings, Inc.
695 Town Center Drive, Suite 260
Costa Mesa, CA 92626
Attention: Chief Executive Officer
If to the
Holder, addressed to: c/o
Strategic Global Management, Inc.
6800 Indiana Avenue, Suite 130
Riverside, CA 92506
Attention: William E. Thomas, Esq.
12.4 GOVERNING LAW.
This Warrant shall be governed by and construed
under the laws of the State of California as applied to agreements among
California residents entered into and to be performed entirely within
California.
12.5 ENTIRE AGREEMENT.
This Warrant, the exhibits and schedules
hereto, and the documents referred to herein, constitute the entire
agreement
and understanding of the parties hereto with respect to the subject
matter
hereof, and supersede all prior and contemporaneous agreements and
understandings, whether oral or written,
between the parties hereto with respect
to the subject matter hereof.
5
<PAGE>
12.6 BINDING
EFFECT. This Warrant and the various rights and
obligations arising hereunder shall inure to
the benefit of and be binding upon
the Company and its successors and assigns, and Holder and its successors
and
assigns.
12.7 WAIVER;
CONSENT. This Warrant may not be changed,
amended,
terminated, augmented, rescinded or discharged (other
than by performance), in
whole or in part, except by a writing executed by the parties
hereto, and no
waiver of any of the provisions or conditions of this Warrant or any of the
rights of a party hereto shall be effective
or binding unless such
waiver shall
be in writing and signed by the party claimed to have given or consented
thereto.
12.8 SEVERABILITY.
If one or more
provisions
of this Warrant
are
held to be unenforceable under applicable law, such
provision shall be excluded
from this Warrant and the balance of the
Warrant shall be interpreted as if such
provision were so excluded and the balance
shall be enforceable
in accordance
with its terms.
12.9 DISPUTE RESOLUTION. In the event of any dispute
arising out of
or relating to this Warrant, such dispute shall be resolved solely and
exclusively by confidential binding
arbitration with the Orange County branch of
JAMS ("JAMS") to be governed by JAMS'
Commercial Rules of
Arbitration in effect
at the time of the commencement of the arbitration
(the "JAMS RULES") and heard
before one arbitrator. The parties shall attempt to mutually select the
arbitrator. In the event they are unable to
mutually agree, the arbitrator shall
be selected by the procedures prescribed by the JAMS Rules. Each party shall
bear its own attorneys' fees, expert witness fees, and costs incurred in
connection with any arbitration.
IN WITNESS
WHEREOF, the parties
have executed this Warrant as of the date
first above written.
"HOLDER":
-----------------------------------------
WILLIAM E. THOMAS, an individual
"COMPANY":
INTEGRATED HEALTHCARE HOLDINGS, INC.,
a Nevada corporation
By:
--------------------------------------
Larry B. Anderson, President
6
<PAGE>
NOTICE OF EXERCISE
To: INTEGRATED HEALTHCARE HOLDINGS,
INC.
The undersigned hereby
elects to purchase
_____________ shares
of
_________ Stock (the "Shares") of
Integrated Healthcare Holdings, Inc., a Nevada
corporation (the "Company") pursuant to the terms of the
attached Warrant,
and
tenders herewith payment of the purchase price pursuant to the terms of the
Warrant.
Attached as
Exhibit A is an investment represen